SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: winners18 who wrote (36024)6/17/2016 11:27:50 PM
From: gary123  Read Replies (2) of 63324
 
This is what i suspected, with RR, we will know much earlier, in the first cycle. Now the reasons for Immu silence, may be the FDA is studying their proposals and did not make a decision, in this sense mgmt can't comment prematurely. I am not too familiar with the simon stage 2 analysis, but I am assuming if the second cohort of patients mirrors the first set(in the first few months) then "that it". I do expect a press release when the FDA announce their decision.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News